Your browser doesn't support javascript.
loading
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer.
Sugawara, S; Lee, J-S; Kang, J-H; Kim, H R; Inui, N; Hida, T; Lee, K H; Yoshida, T; Tanaka, H; Yang, C-T; Nishio, M; Ohe, Y; Tamura, T; Yamamoto, N; Yu, C-J; Akamatsu, H; Namba, Y; Sumiyoshi, N; Nakagawa, K.
Afiliação
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
  • Lee JS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
  • Kang JH; Department of Medical Oncology, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea.
  • Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Inui N; Department of Pulmonary Medicine, Hamamatsu University Hospital, Shizuoka, Japan.
  • Hida T; Department of Thoracic Oncology, Aichi Cancer Center, Aichi, Japan.
  • Lee KH; Department of Internal Medicine, Chungbuk National University Hospital, Chungcheongbuk-do, Korea.
  • Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Tanaka H; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
  • Yang CT; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Nishio M; Department of Thoracic Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Tamura T; Thoracic Center, St. Luke's International Hospital, Tokyo, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Yu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Akamatsu H; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Namba Y; Clinical Science, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Sumiyoshi N; Oncology Clinical Development Planning 1, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan. Electronic address: nakagawa@med.kindai.ac.jp.
Ann Oncol ; 32(9): 1137-1147, 2021 09.
Article em En | MEDLINE | ID: mdl-34139272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão